562 related articles for article (PubMed ID: 23246047)
1. Heart transplant graft survival is improved after a reduction in panel reactive antibody activity.
Schaffer JM; Singh SK; Reitz BA; Oyer PE; Robbins RC; Mallidi HR
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):555-64; discussion 564-5. PubMed ID: 23246047
[TBL] [Abstract][Full Text] [Related]
2. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
[TBL] [Abstract][Full Text] [Related]
3. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database.
Rossano JW; Morales DL; Zafar F; Denfield SW; Kim JJ; Jefferies JL; Dreyer WJ
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):694-9, 699.e1-2. PubMed ID: 20537356
[TBL] [Abstract][Full Text] [Related]
4. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
Nwakanma LU; Williams JA; Weiss ES; Russell SD; Baumgartner WA; Conte JV
Ann Thorac Surg; 2007 Nov; 84(5):1556-62; discussion 1562-3. PubMed ID: 17954062
[TBL] [Abstract][Full Text] [Related]
5. Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.
Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J
J Am Coll Cardiol; 2013 Dec; 62(24):2308-15. PubMed ID: 23994416
[TBL] [Abstract][Full Text] [Related]
6. Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade.
Jawitz OK; G Jawitz N; Yuh DD; Bonde P
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1239-45; discussion 1245-6. PubMed ID: 23978472
[TBL] [Abstract][Full Text] [Related]
7. Effect of Induction Therapy on Graft Survival in Primary Pediatric Heart Transplantation: A Propensity Score Analysis of the UNOS Database.
Butts R; Davis M; Savage A; Burnette A; Kavarana M; Bradley S; Atz A; Nietert PJ
Transplantation; 2017 Jun; 101(6):1228-1233. PubMed ID: 27362312
[TBL] [Abstract][Full Text] [Related]
8. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
Freitas MC
Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
[TBL] [Abstract][Full Text] [Related]
9. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
10. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
11. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
Weiss ES; Allen JG; Patel ND; Russell SD; Baumgartner WA; Shah AS; Conte JV
Circ Heart Fail; 2009 Sep; 2(5):401-8. PubMed ID: 19808369
[TBL] [Abstract][Full Text] [Related]
12. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.
Kluger MD; Guarrera JV; Olsen SK; Brown RS; Emond JC; Cherqui D
Transplantation; 2012 Sep; 94(5):526-31. PubMed ID: 22874840
[TBL] [Abstract][Full Text] [Related]
13. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
Weiss ES; Nwakanma LU; Patel ND; Yuh DD
J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
[TBL] [Abstract][Full Text] [Related]
15. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant Panel Reactive Antibodies and Lung Transplant Outcomes in Children.
Hayes D; Kopp BT; Sheikh SI; Shell RD; Paul GR; McConnell PI; Tobias JD; Tumin D
Thorac Cardiovasc Surg; 2017 Jan; 65(1):36-42. PubMed ID: 27595243
[No Abstract] [Full Text] [Related]
17. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
[TBL] [Abstract][Full Text] [Related]
18. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
Graff RJ; Xiao H; Duffy B; Schnitzler MA; Axelrod D; Lentine KL
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):234-45. PubMed ID: 22382213
[TBL] [Abstract][Full Text] [Related]
19. Current outcomes in US children with cardiomyopathy listed for heart transplantation.
Singh TP; Almond CS; Piercey G; Gauvreau K
Circ Heart Fail; 2012 Sep; 5(5):594-601. PubMed ID: 22899768
[TBL] [Abstract][Full Text] [Related]
20. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
